¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022³â ´ëÇѼö¸éÇÐȸ Á¤±âÇмú´ëȸ II : 2022-11-27

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022³â ´ëÇѼö¸éÇÐȸ Á¤±âÇмú´ëȸ II : 2022-11-27
±³À°ÀÏÀÚ : 2022-11-27
±³À°Àå¼Ò : ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ 5Ãþ  
±³À°ÁÖÁ¦ : 2022³â ´ëÇѼö¸éÇÐȸ Á¤±âÇмú´ëȸ II 
ÁÖÃÖ±â°ü : ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѼö¸éÇÐȸ  
´ã´çÀÚ : ´ëÇѼö¸éÇÐȸ
¿¬¶ôó : 02-545-5373  
À̸ÞÀÏ : entsoc@korl.or.kr      
±³À°Á¾·ù : À̺ñÀÎÈÄ°ú      
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í 100,000(Àü°øÀÇ/ÀÇ·á±â»ç/±âŸ 50,000¿ø)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 09:30~10:15 OSA pathophysiology  Emmanuel Mignot(Stanford Center for Sleep Sciences and Medicine) 
±³À°½Ã°£ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 10:15~10:50 Community-based Ansan Cohort Study - Present/Future  ½Åö(°í·Á´ë ¾È»êº´¿ø È£Èí±â ³»°ú) 
È޽Ġ11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 10:50~11:10 Break  () 
±³À°½Ã°£ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 11:10~11:30 Updates on the relationship between melatonin and cognition  ¾öÀ¯Çö(°¡Å縯ÀÇ´ë Á¤½Å°Ç°­ÀÇÇаú) 
±³À°½Ã°£ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 11:30~11:50 Updates on the melatonin-based drug efficacy on insomnia  ±è¼ºÀç(Á¶¼±ÀÇ´ë Á¤½Å°Ç°­ÀÇÇаú) 
±³À°½Ã°£ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 11:50~12:10 Updates on the efficacy of melatonin on REM sleep behavior disorder  ±è¼º¹Î(HÇ÷¯½º¾çÁöº´¿ø) 
½Ä»ç 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 12:10~13:20 Lunch  () 
±³À°½Ã°£ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 13:20~13:40 Novel metrics for evaluating the obstructive sleep apnea, beyond AHI  ¹ÚÇý¸®(ÀÏ»ê¹éº´¿ø ½Å°æ°ú) 
±³À°½Ã°£ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 13:40~14:00 A new EEG-based scale reflecting sleep depth and arousability  ±èµ¿¿±(ÀÌ´ë¼­¿ïº´¿ø ½Å°æ°ú) 
±³À°½Ã°£ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 14:00~14:20 Brain functional network based on sleep EEG in sleep disorders  ±è¼º±Ç(ÇѾç´ë ½º¸¶Æ®À¶ÇÕºÎ) 
±³À°½Ã°£ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 14:20~14:35 Change in oxygen saturation levels following oral appliance treatment for OSA  ¹ÚÁö¿î(¼­¿ï´ë ±¸°­³»°ú) 
±³À°½Ã°£ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 14:35~14:50 Compliance and side effects of oral appliances  ±èÁö¶ô(°æºÏ´ë ±¸°­³»°ú) 
±³À°½Ã°£ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 14:50~15:05 Maxillary expansion for treatment of OSA  ±èÀ±Áö(¼­¿ï¾Æ»ê Ä¡°ú±³Á¤°ú) 
±³À°½Ã°£ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 15:05~15:20 Customized maxillofacial surgical treatment for OSA  È«¼º¿Á(°æÈñ´ë ±¸°­¾Ç¾È¸é¿Ü°ú) 
È޽Ġ11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 15:20~15:40 Break  () 
±³À°½Ã°£ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 15:40~16:00 COVID 19 & sleep breathing disorder  ¹Ú¼ºÈÆ(ÇѸ²ÀÇ´ë ÆòÃ̼º½Éº´¿ø È£Èí±â³»°ú &ÁßȯÀÚÀÇÇаú) 
±³À°½Ã°£ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 16:00~16:20 Lung cancer & sleep breathing disorder  ±è¼¼¿ø(°¡Å縯ÀÇ´ë ÀºÆò¼º¸ðº´¿ø) 
±³À°½Ã°£ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 16:20~16:40 Pediatric OSA in COVID-19  ¼ÛÁÖ¿µ(°­³²Â÷º´¿ø ¼Ò¾Æû¼Ò³â°ú) 
±³À°½Ã°£ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 16:40~17:00 Respiratory Event ScoringÀÇ tip°ú À¯ÀÇÁ¡  Á¶À翵(¼­¿ï´ëº´¿ø È£Èí±â³»°ú) 
Åä·Ð 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 17:00~17:20 Panel discussion  () 
±âŸ 11-27 ¼­¿ï´ëÇб³ ±Û·Î¹ú°øÇб³À°¼¾ÅÍ ´ë°­´ç 17:00~17:30 Closing (General assembly)  Á¤À¯»ï(¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø À̺ñÀÎÈÄ°ú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022³â ´ëÇѼö¸éÇÐȸ Á¤±âÇмú´ëȸ II : 2022-11-27""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÀÌ°úÇÐȸ (¿Â¶óÀÎ) 2022 ÀÌ°úÇÐ Live Surgery ¹× ½ÅÀÇ·á±â¼ú ¼¼¹Ì³ª : 2022-11-27
´ÙÀ½±Û 2022 ´ëÇѽŰæ¿Ü°úÃÊÀ½ÆÄÇÐȸ Á¦15Â÷ Çмú´ëȸ : 2022-11-27
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 86 2024-05-28
20896 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 161 2024-05-28
20895 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 119 2024-05-28
20894 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 50 2024-05-28
20893 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 70 2024-05-28
20892 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 46 2024-05-28
20891 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 67 2024-05-28
20890 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 166 2024-05-27
20889 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 102 2024-05-27
20888 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 217 2024-05-27
20887 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 99 2024-05-27
20886 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 49 2024-05-27
20885 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 57 2024-05-27
20884 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 83 2024-05-27
20883 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 68 2024-05-27
21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷